Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Published Online
on January 20, 2003

Hypertension. 2003
Published online before print January 20, 2003, doi: 10.1161/01.HYP.0000051502.93374.1C
A more recent version of this article appeared on February 1, 2003
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
41/2/373    most recent
01.HYP.0000051502.93374.1Cv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cingolani, H. E.
Right arrow Articles by Camilión de Hurtado, M. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cingolani, H. E.
Right arrow Articles by Camilión de Hurtado, M. C.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*High Blood Pressure
Related Collections
Right arrow Hypertension - basic studies
Right arrow Hypertrophy
Right arrow Ion channels/membrane transport

Submitted on September 9, 2002
Revised on September 30, 2002

Regression of Hypertensive Myocardial Fibrosis by Na+/H+ Exchange Inhibition

Horacio E. Cingolani*; Oscar R. Rebolledo; Enrique L. Portiansky; Néstor G. Pérez; and María C. Camilión de Hurtado

From Centro de Investigaciones Cardiovasculares, Facultad de Ciencias Médicas and Facultad de Ciencias Veterinarias, Universidad Nacional de La Plata, Argentina.

* To whom correspondence should be addressed. E-mail: cicmes{at}infovia.com.ar.

Abstract--We have recently reported that the inhibition of the Na+/H+ exchanger (NHE) during 1 month in spontaneously hypertensive rats (SHR) is followed by regression of cardiomyocyte hypertrophy but not of myocardial fibrosis. The aim of this study was to evaluate whether a treatment of longer duration could reduce myocardial fibrosis and stiffness. SHR received 3.0 mg/kg per day of the specific NHE-1 inhibitor cariporide; the effect on cardiomyocyte cross-sectional area, myocardial collagen volume fraction, collagen synthesis, and myocardial stiffness (length-tension relation in left papillary muscles) was evaluated at several time points (after 1, 2, or 3 months). A slight decrease of {approx}5 mm Hg in systolic blood pressure was observed after 1 month of treatment with no further changes. After 2 and 3 months of treatment, the size of cardiomyocytes remained within normal values and myocardial fibrosis progressively decreased to normal level. Accordingly, myocardial stiffness and the serum levels of the carboxyterminal propeptide of procollagen type I, a marker of collagen type I synthesis, were normalized after 3 months. Left ventricular weight decreased from 910±43 (in untreated SHR) to 781±21 mg (treated SHR) after 3 months of treatment. No difference in body weight between treated and untreated SHR was observed after this period of treatment. The present data allow us to conclude that in the SHR the administration of an NHE-1 inhibitor for 2 or 3 months leads to the normalization of collagen type I synthesis, myocardial collagen volume fraction, and stiffness.


Key words: fibrosis • myocardium • extracellular matrix • signal transduction




This article has been cited by other articles:


Home page
J. Appl. Physiol.Home page
C. D. Garciarena, C. I. Caldiz, E. L. Portiansky, G. E. Chiappe de Cingolani, and I. L. Ennis
Chronic NHE-1 blockade induces an antiapoptotic effect in the hypertrophied heart
J Appl Physiol, April 1, 2009; 106(4): 1325 - 1331.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
X. Li, P. Karki, L. Lei, H. Wang, and L. Fliegel
Na+/H+ exchanger isoform 1 facilitates cardiomyocyte embryonic stem cell differentiation
Am J Physiol Heart Circ Physiol, January 1, 2009; 296(1): H159 - H170.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. Imahashi, F. Mraiche, C. Steenbergen, E. Murphy, and L. Fliegel
Overexpression of the Na+/H+ exchanger and ischemia-reperfusion injury in the myocardium
Am J Physiol Heart Circ Physiol, May 1, 2007; 292(5): H2237 - H2247.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
N. G. Perez, M. R. Piaggio, I. L. Ennis, C. D. Garciarena, C. Morales, E. M. Escudero, O. H. Cingolani, G. Chiappe de Cingolani, X.-P. Yang, and H. E. Cingolani
Phosphodiesterase 5A Inhibition Induces Na+/H+ Exchanger Blockade and Protection Against Myocardial Infarction
Hypertension, May 1, 2007; 49(5): 1095 - 1103.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
H. E. Cingolani and I. L. Ennis
Sodium-Hydrogen Exchanger, Cardiac Overload, and Myocardial Hypertrophy
Circulation, March 6, 2007; 115(9): 1090 - 1100.
[Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. Javadov, D. Baetz, V. Rajapurohitam, A. Zeidan, L. A. Kirshenbaum, and M. Karmazyn
Antihypertrophic Effect of Na+/H+ Exchanger Isoform 1 Inhibition Is Mediated by Reduced Mitogen-Activated Protein Kinase Activation Secondary to Improved Mitochondrial Integrity and Decreased Generation of Mitochondrial-Derived Reactive Oxygen Species
J. Pharmacol. Exp. Ther., June 1, 2006; 317(3): 1036 - 1043.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. Kilic, A. Velic, L. J. De Windt, L. Fabritz, M. Voss, D. Mitko, M. Zwiener, H. A. Baba, M. van Eickels, E. Schlatter, et al.
Enhanced Activity of the Myocardial Na+/H+ Exchanger NHE-1 Contributes to Cardiac Remodeling in Atrial Natriuretic Peptide Receptor-Deficient Mice
Circulation, October 11, 2005; 112(15): 2307 - 2317.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
S. Meiners, B. Hocher, A. Weller, M. Laule, V. Stangl, C. Guenther, M. Godes, A. Mrozikiewicz, G. Baumann, and K. Stangl
Downregulation of Matrix Metalloproteinases and Collagens and Suppression of Cardiac Fibrosis by Inhibition of the Proteasome
Hypertension, October 1, 2004; 44(4): 471 - 477.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. Aker, A. K Snabaitis, I. Konietzka, A. van de Sand, K. Bongler, M. Avkiran, G. Heusch, and R. Schulz
Inhibition of the Na+/H+ exchanger attenuates the deterioration of ventricular function during pacing-induced heart failure in rabbits
Cardiovasc Res, August 1, 2004; 63(2): 273 - 282.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
O. H. Cingolani, X.-P. Yang, Y.-H. Liu, M. Villanueva, N.-E. Rhaleb, and O. A. Carretero
Reduction of Cardiac Fibrosis Decreases Systolic Performance Without Affecting Diastolic Function in Hypertensive Rats
Hypertension, May 1, 2004; 43(5): 1067 - 1073.
[Abstract] [Full Text] [PDF]